Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
2 investors
CroΓValve develops the DUO System, a minimally invasive heart valve device designed to treat tricuspid regurgitation, a common and often underdiagnosed heart condition. The company targets patients suffering from this disease across the US and Europe.
2 investors
Crossbow Therapeutics develops TCR-mimetic antibody therapies designed to target cancer antigens by mimicking T-cell receptors, with a focus on treating solid tumors and hematologic malignancies. The company creates next-generation T-cell engagers incorporating its proprietary T-Boltβ’ molecules to enhance therapeutic potency and manufacturability.
2 investors
CureApp develops evidence-based prescription therapeutic apps (software as a medical device / digital therapeutics) to treat conditions where conventional drugs or hardware devices fall short, delivering personalized follow-up and behavior change outside clinical visits. It also offers corporate mobile health programs for occupational health and workplace wellness.
2 investors
Curve Health operates a telemedicine platform combined with data analytics and health information exchange that connects bedside providers with remote clinicians. It focuses on long-term care, serving nursing home and skilled nursing facility residents, their caregivers, and clinicians.
2 investors
CustoMED offers a software platform for personalized surgery that turns medical imaging into 3D anatomical models and supports AI-assisted surgical planning and production of patient-specific outputs such as implants, cut and drill guides, and surgical plans. It serves surgeons, medical centers, implant manufacturers, and 3D labs, primarily for orthopedic indications.
2 investors
CYBERDYNE develops wearable cyborg technology, including the HAL exoskeleton used for functional improvement and rehabilitation treatment, along with medical vital sensors such as the Cyvis M100 compact Holter electrocardiograph. The Japanese company applies its "cybernics" technology across medical rehabilitation, robotic care centers, and healthcare monitoring.
2 investors
Cybrexa is a biotechnology company developing cancer therapeutics that use its alphalex peptide-drug conjugate platform to target the low-pH tumor microenvironment for selective delivery. The technology aims to enable more potent drugs and combination therapies and to expand the efficacy of existing anticancer agents.
2 investors
CytoGen Lab develops liquid biopsy technology for cancer detection through circulating tumor cell (CTC) isolation from blood samples, combining biotechnology and engineering for precision medicine applications.
2 investors
Dante Labs provides clinical-grade whole genome sequencing services for individuals seeking genetic insights into hereditary disease risk, diagnostic clarity for unexplained symptoms, treatment optimization, and proactive health planning. The company delivers comprehensive genomic analysis as an alternative to limited consumer DNA tests, with results presented in 200+ physician-ready clinical reports.
2 investors
Data Innovations builds laboratory middleware that connects lab instruments, LIS, and EMR/EHR systems across disciplines, consolidating testing control into one platform. Its Instrument Manager offers autoverification, customizable rules, specimen management, and lab intelligence for clinical laboratories.
2 investors
Decimal Code provides revenue cycle AI solutions for healthcare organizations, leveraging machine learning to optimize medical coding, prior authorization, and billing processes. The company's platform is built on 15 million de-identified cases from 84 research hospitals and is designed for hospital finance teams and revenue cycle managers.
2 investors
DEWI11 is an online gaming platform that provides information and articles about online games, including game updates, seasonal changes, new features, and strategies for players.
2 investors
Delpor develops subcutaneous implant devices that deliver therapeutic drugs over extended periods (6-12 months) for chronic condition treatment. The company's passive implant technology enables sustained-release drug delivery through simple in-office procedures, targeting improved patient adherence and consistent pharmacokinetic profiles.
2 investors
Detect develops molecular diagnostic tests that combine nucleic acid amplification with lateral flow hardware to deliver PCR-level accuracy without lab work, returning results in about one hour. Its consumer testing platform started with COVID-19 detection and is designed to adapt to other pathogens, with stated ambitions in women's health diagnostics.
2 investors
Devoro Medical developed the WOLF Thrombectomy Platform, a non-console, lytic-free medical device that uses finger-like prongs to capture and remove blood clots (thrombi) from the arterial and venous systems. The technology serves physicians performing thrombectomy procedures for clot management.
2 investors
Diag-Nose.io develops AI-powered precision diagnostics for respiratory diseases using nasal microsampling, proteomics, and machine learning algorithms. The platform targets patients and clinicians to enable personalized treatment selection and improve outcomes for chronic respiratory conditions like asthma, COPD, and chronic sinusitis.
2 investors
DIANA Biotechnologies develops PCR and RT-PCR reagents, custom oligonucleotide synthesis, monoclonal antibodies, ultrasensitive sepsis diagnostics, and kinase inhibitor profiling services for diagnostic and academic laboratories. The company relies on its PCR expertise and proprietary DIANA technology, with products available across 18 European countries.
2 investors
Digital Surgery offers the Touch Surgery ecosystem, an AI-powered platform for recording, accessing, and analyzing surgical video in a secure cloud-based library to support post-operative review and performance assessment. It serves surgeons and OR teams and includes a free app of surgical scenarios across multiple specialties for training and preparation.
2 investors
Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus. The device is designed for use in standard GI endoscopy suites and serves gastroenterology clinicians treating pre-cancerous and other GI pathologies.
2 investors
Dignify Therapeutics develops "on demand" drugs that trigger emptying of the bladder and/or bowel when a person chooses, aimed at restoring control of bowel and bladder function. It operates in the biotechnology and pharmaceutical space focused on therapeutics for people with impaired bladder and bowel control.
2 investors
Ditch Labs develops a prescription medical inhaler combining nicotine replacement therapy with a digital app for personalized smoking and vaping cessation programs. The company targets smokers and vaping users seeking evidence-based methods to quit tobacco use.
2 investors
DIVE-Medical develops eye tracking and artificial intelligence technology for objective visual function assessment in children and non-verbal patients. The system detects refractive disorders, amblyopia, strabismus, and other ocular pathologies from six months of age across clinical examination and screening applications.
2 investors
DME Express is a durable medical equipment supplier offering products such as hospital beds, mattresses, oxygen and respiratory equipment, wheelchairs, mobility aids, bariatric equipment, bathroom safety items, and patient lifts. It operates 60+ warehouse locations across multiple US states.
2 investors